Business Description
Alterity Therapeutics Ltd
ISIN : AU0000043945
Compare
Compare
Traded in other countries / regions
ATH.AustraliaPBN.GermanyATHE.USA Description
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 75.11 | |||||
| Equity-to-Asset | 0.84 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | N/A |
N/A
|
N/A
| |||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 26.3 | |||||
| 3-Year EPS without NRI Growth Rate | 26.3 | |||||
| 3-Year FCF Growth Rate | 10.1 | |||||
| 3-Year Book Growth Rate | 8.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 0.02 | |||||
| 6-1 Month Momentum % | -95.45 | |||||
| 12-1 Month Momentum % | -96.3 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.17 | |||||
| Quick Ratio | 6.17 | |||||
| Cash Ratio | 3.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -33 | |||||
| Shareholder Yield % | -5.52 |
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.56 | |||||
| EV-to-EBIT | -0.74 | |||||
| EV-to-EBITDA | -0.75 | |||||
| EV-to-FCF | -1.29 | |||||
| Earnings Yield (Greenblatt) % | -135.14 | |||||
| FCF Yield % | -31.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PRNAF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alterity Therapeutics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.004 | ||
| Beta | -3.09 | ||
| Volatility % | 1056.74 | ||
| 14-Day RSI | 0.02 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.0002 | ||
| 12-1 Month Momentum % | -96.3 | ||
| 52-Week Range ($) | 0.0002 - 0.02235 | ||
| Shares Outstanding (Mil) | 5,238.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alterity Therapeutics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alterity Therapeutics Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Alterity Therapeutics Ltd Frequently Asked Questions
What is Alterity Therapeutics Ltd(PRNAF)'s stock price today?
The current price of PRNAF is $0.00. The 52 week high of PRNAF is $0.02 and 52 week low is $0.00.
When is next earnings date of Alterity Therapeutics Ltd(PRNAF)?
The next earnings date of Alterity Therapeutics Ltd(PRNAF) is 2024-04-28 Est..
Does Alterity Therapeutics Ltd(PRNAF) pay dividends? If so, how much?
Alterity Therapeutics Ltd(PRNAF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers